FOR: CARDIOCOMM SOLUTIONS, INC.
TSX VENTURE SYMBOL: EKG
December 4, 2018
TORONTO, ONTARIO - Established medial electrocardiogram ("ECG") software and device manufacturer CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") today confirmed the appointment of a new Chief Financial Officer ("CFO"), Ms. Anne Burpee.
Ms. Burpee is a bilingual Chartered Professional Accountant with more than 25 years of senior finance and executive experience in both large and small companies. She has held several corporate positions in enterprises ranging from private company start-ups to TSX and NYSE publicly-listed corporations and multinationals, where she led financial reporting, corporate governance, change management, administration, tax, legal and IT. Previous employers where Ms. Burpee has worked in a senior capacity include: AON Hewitt, Global Aerospace Underwriting Managers, South Western Insurance Group, Canadian Tire, and Sears Canada. Ms. Burpee is a graduate of McGill University and holds a CPA CMA designation in Ontario. In addition, she is a financial literacy volunteer for CPA Canada and a member of the Accounting Program Advisory Committee at Humber College.
The Company thanks its outgoing US-based CFO, Mr. John Overall, for his support during a restructuring of the Company's financial systems, planning and internal controls that started in 2016. Additionally, in the role of CFO, Mr. Overall led the Company through the completion of several phases of preparatory work in anticipation of new IFRS reporting requirements. With these changes in place the Company is now ready for a new phase of growth to be supported by its new Toronto-based CFO.
To learn more about the CardioComm Solutions' products and for further updates regarding HeartCheck™ ECG device integrations, please see the Company's websites www.cardiocommsolutions.com and www.theheartcheck.com.
CardioComm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada). CardioComm Solutions, Inc. is headquartered in Toronto, Canada.
INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
This release may contain certain forward-looking statements and forward looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management's current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.